Immunotherapy Blocks Scarring, Improves Heart Function in Mice with Heart Failure

Researchers at WashU Medicine have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to one approved by the FDA for other conditions. The findings point to the possibility of developing such immunotherapies for heart failure in patients who have experienced a heart attack or other injury. 

Read More